| Challenges in validation of combination treatment strategies for CRC using patient-derived organoids | Journal of experimental & clinical cancer research |  | | 2024 | 42 | 68 |
|
| Personalised drug combination platform for effective colorectal cancer treatment | | | | 2023 | 428 | 110 |
|
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | | | 2023 | 182 | 96 |
|
| FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells | Cancers | | | 2022 | 256 | 189 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 445 | 195 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules | | | 2020 | 386 | 351 |
|
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | | | 2020 | 348 | 356 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers | | | 2019 | 544 | 350 |
|
| Investigating the mechanism of enhanced cytotoxic activity of optimized combination therapies for cancer treatment | |  | | 2017 | 95 | 7 |
|
